Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2026-01-26 @ 9:31 PM
Study NCT ID:
NCT00790218
Status:
COMPLETED
Last Update Posted:
2022-05-17
First Post:
2008-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma
Sponsor:
Can-Fite BioPharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
ACTUAL
Primary Completion Date:
2012-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-11
First Submit QC Date:
None
Study First Post Date:
2008-11-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-08-12
Results First Submit QC Date:
None
Results First Post Date:
2015-02-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-23
Last Update Post Date:
2022-05-17
Last Update Post Date Type:
ACTUAL